Neurons are highly polarized cells with distinct protein compositions in axonal and dendritic compartments. Cellular mechanisms controlling polarized protein sorting have been described for mature nervous system but little is known about the segregation in newly differentiated neurons. In a forward genetic screen for regulators of Drosophila brain circuit development, we identified mutations in SPT, an evolutionary conserved enzyme in sphingolipid biosynthesis. Here we show that reduced levels of sphingolipids in SPT mutants cause axonal morphology defects similar to loss of cell recognition molecule Dscam. Loss-and gainof-function studies show that neuronal sphingolipids are critical to prevent aggregation of axonal and dendritic Dscam isoforms, thereby ensuring precise Dscam localization to support axon branch segregation. Furthermore, SPT mutations causing neurodegenerative HSAN-I disorder in humans also result in formation of stable Dscam aggregates and axonal branch phenotypes in Drosophila neurons, indicating a causal link between developmental protein sorting defects and neuronal dysfunction.
N eurons are highly polarized cells with morphologically and functionally specialized axonal and dendritic compartments. This functional polarity is maintained by having a strict control on intra-cellular transport of vesicles carrying cargo destined for different neuronal compartments [1] [2] [3] . Although substantial progress has been achieved in the understanding of compartment-specific protein sorting in the mature nervous system 1-5 , we still have little insights into the developmental mechanisms controlling initial segregation of axonal and dendritic proteins involved in neuronal patterning 5 .
In addition to proteins, lipids define a major component of transport vesicles. Sphingolipids, typified by the presence of the long chain amino-alcohol sphingosine, are enriched in certain cellular membranes and are a major constituent of lipid rafts, specialized signaling centers in the plasma membrane [6] [7] [8] . Additionally, sphingolipids can regulate the segregation of cargos for polarized intra-cellular transport at the trans-golgi network 9 . In cultured hippocampal neurons, chemical inhibition of sphingolipid biosynthesis affects axonal outgrowth and transport of axonally targeted proteins 10, 11 . However, in vivo analysis for the role of sphingolipids in polarized transport and their role in neuronal patterning and survival is largely unexplored.
The Down syndrome cell adhesion molecule (Dscam) regulates early developmental patterning of dendrites and axons in Drosophila 12 . Cell-intrinsic function of Dscam has been implicated in self avoidance of growing axons and dendrites and for the proper development of axonal connectivity [13] [14] [15] [16] [17] [18] [19] . These neurite patterning activities are tightly associated with the specific intra-neuronal distribution of Dscam isoforms which differ in the transmembrane domains TM1 and TM2 [20] [21] [22] . Dscam[TM1] isoforms are localized to dendrites and control dendritic patterning 13, [20] [21] [22] , whereas axon branching depends on Dscam[TM2] isoforms [17] [18] [19] [20] [21] [22] [23] . Thus, Dscam is a unique molecule whose cell-intrinsic function in neurite patterning depends on differential intra-cellular distribution.
Here we describe a novel role of sphingolipids in regulating the subcellular distribution of Dscam in Drosophila Mushroom Body (MB) neurons. The reduction in sphingolipids interferes with the initial segregation of dendritic and axonal Dscam isoforms thereby resulting in Dscam-associated neuronal patterning defects. Furthermore, the disruption of Dscam sorting is associated with the formation of stable protein aggregates, which translocate into the axonal compartment, suggesting related pathological mechanisms in human neurological disorders associated with a perturbed sphingolipid biosynthesis 24, 25 .
Results
Loss of SPT leads to Dscam-mutant phenotypes. In a mosaic screen for identifying genes involved in Dscam-mediated neuronal patterning, we identified mutations in the two subunits of Serine Palmitoyltransferase (SPT), the key enzyme of de novo sphingolipid biosynthesis, encoded by the genes Spt-I and lace 26 (Fig. 1a ). The mammalian homologs SPTLC1 and SPTLC2 assemble into a large protein multimer, which localizes to the ER membrane 27, 28 (Fig. 1b) . In Drosophila, hypomorphic lace mutants show a strong reduction in sphingolipid levels accompanied by enhanced cell death in imaginal discs and defective glial development [29] [30] [31] [32] [33] . The newly identified Spt-I B2 allele carries a point mutation (G127E) in the amino-transferase (AT) domain. Similarly, a single point mutation could be identified in lace U2 (C570T), which also maps to the predicted AT domain 26 (Fig. 1a ). In genetic complementation analyses, Spt-I B2 and lace U2 classified as strong hypomorphic mutations (Supplementary Figure 1A ), suggesting a severe reduction or loss of protein function. Consistent with this, Spt-I and lace trans-heterozygotes showed lower levels of total ceramide as compared to control, further reduced in Spt-I and lace double mutant combination but no change in membrane phospholipid Phosphatidylcholine (PC) ( Fig. 1c, Supplementary Figure 1B , Supplementary Data 1).
In the Drosophila olfactory system, olfactory receptor neurons (ORNs) homozygous mutant for Spt-I fail to reach their target glomerulus in the brain but converge ectopically, which is similar to Dscam-mutant ORNs (Fig. 1d-h ). In the central brain, developing MB neurons require SPT function to segregate axonal branches into distinct lobes. This results in SPT mutants showing a "lost-lobe" phenotype indistinguishable from Dscammutant MB defects 15 (Fig. 1i-t, z) . Mutations in regulatory subunit Spt-I shows lower penetrance but identical axonal phenotypes as compared to the enzymatic subunit lace 26 in the olfactory system and MB ( Fig. 1d-h , i-p, z). Single cell analysis revealed a failure of lace mutant MB neurons to extend their axon branches dorsally but instead develop two parallel horizontal branches which has been described before following the loss of Dscam 15 (Fig. 1u-y) . A pan-neuronal reduction of sphingolipids via lace RNAi showed the same but less frequent MB defects, confirming SPT function in nervous system development ( Fig. 1z) . Removing a copy of Spt-I in hypomorphic lace mutants (or vice versa) increases the penetrance and expressivity of MB axonal defects, indicating a direct functional interaction between the two SPT subunits in neuronal patterning ( Fig. 1i -p, z). In addition, various allelic combinations showed strong genetic interactions between SPT and Dscam in MB and ORN targeting (e.g., Dscam, Spt-I/ + and Dscam, Spt-I/lace; Fig. 1q -t, z and Supplementary Figure 2 ). The lace mutant neuronal defects can be rescued by the expression of a wild-type transgene not only in developing neurons (Dscam-Gal4) but also in glia cells (repo-Gal4), suggesting a non-cell autonomous supply of sphingolipids 34 (Fig. 1z ). This is supported by a lack of phenotype in small SPT MARCM clones, showing that a loss of SPT function in developing neurons can be compensated by surrounding wildtype cells ( Supplementary Figure 3 ). Knockdown of other enzymes catalyzing various steps of sphingolipid biosynthesis pathway also show MB lost-lobe phenotype, indicating lack of sphingolipids but not of a specific enzyme as the main factor leading to developmental defects in the nervous system (Supplementary Figure 4 ). This is further confirmed by the complementation of SPT function by sphingosine food supplementation leading to a significant reduction of neuronal defects in SPT mutants ( Fig. 1h ).
These data show that mutations in each of the SPT subunits result in a Dscam-like phenotype in the Drosophila nervous system. The synergistic interaction of Spt-I and Lace in early neuronal development is supporting the proposed functions of the two SPT subunits in the regulation of sphingolipid synthesis 26 . In addition, the rescue of SPT mutant neurons by surrounding wild-type tissue indicates a direct effect of sphingolipid levels in the brain.
Neuron class-specific role of sphingolipids in MB development.
As Drosophila MB consist of three main neuronal subtypes of Kenyon cells, α/β, α′/β′ and γ neurons, which organizes their axons into distinct lobe neuropils 35 (Fig. 2a, b ), we next analyzed neuron class-specific defects in SPT mutants. The α′/β′ neurons develop before the α/β neurons and axons of both classes tightly associate in the lobe region (Fig. 2d ). The differential labeling of both MB classes in SPT mutants showed a strict co-occurrence of the α/α′ lobe defect supporting a previously described interdependency of α branches on the earlier formed α′ branches during Dscam-mediated axon pattering 15 (Fig. 2d, g) . Although co-projecting into the same direction, neuronal identity is not changed in SPT mutants, as α′/β′ and α/β axons still segregate into distinct horizontal lobes ( Fig. 2d , e, g, h). In contrast, γ neurons, which do not form a vertical axon lobe in the adult brain, seem not affected in SPT mutants ( Fig. 2c, f ).
Next, we determined the developmental onset of MB defects in SPT mutants. In wild type, MB neuron subtypes are generated in a fixed developmental sequence ( Fig. 2i , j-n). In accordance with the adult phenotype, in SPT mutants the formation of larval γ neurons is unaffected, segregating axon branches into two distinct lobes ( Fig. 2o, p Figure 5 for anti-Flamingo staining and Fig. 2p, q) . Similarly, α/β neurons do not project an axon branch vertically in SPT mutant pupae, leading to the "lost-lobe phenotype" in adults ( Fig. 2r ,s). Interestingly, initial axon extension into the proximal MB peduncle, known to require Dscam function 22 , is not affected in SPT mutants demonstrating a tight functional correlation between Dscam and sphingolipids for branch segregation at the distal axonal region ( Fig. 2, Supplementary Figure 5 ).
Sphingolipid-dependent Dscam localization. As the morphological changes in SPT mutant neurons were similar to Dscam, we decided to analyze the distribution of two transmembrane Dscam isoforms in SPT mutants. In wild type neurons, Dscam shows a distinct intra-cellular localization, depending on two alternative trans-/juxta-membrane domains: [20] [21] [22] Dscam[TM1] localizes to the dendritic compartment, the MB calyx ( Fig. 3a ), whereas Dscam[TM2] is distributed throughout the neuronal membrane and enriched in axons ( Fig. 3i , also see Figure Dscam [TM1] interferes with Dscam[TM2] function in SPT mutant MB neurons panels d, e). In SPT mutants, this compartment-specific Dscam[TM1]/ [TM2] sorting is severely affected. In mutant brains, dendritic Dscam[TM1] strongly accumulates in neuronal cell bodies of MBs. In addition, a mislocalization of dendritic Dscam[TM1] isoform to the axonal compartment, enriching in the MB lobes, can be observed ( Fig. 3a-f Axonal protein localization requires sphingolipids. To determine the importance of sphingolipids in the general organization of MB neurons, we analyzed the intra-cellular distribution of additional compartment-specific proteins. The overall dendrite organization, as indicated by microtubule polarity (nod::GFP) as well as the compartment identity shown by the restricted localization of Apc2::GFP and DenMark::Cherry 36,37 , seems unaffected in SPT mutant MB neurons ( Fig. 5a-f ). In contrast, aggregates of FasII 38 as well as Synaptotagmin::GFP (Syt::GFP) 39 can be detected in the somato-dendritic compartment of MB neurons, following early sphingolipid depletion ( Fig. 5f , g-i). Similar to Dscam protein aggregates, the phenotypic severity of FasII aggregation directly correlates with the allelic strength ( Fig. 5g -i). Interestingly, FasII and Dscam[TM1] aggregates often colocalize but also segregate into distinct protein aggregates in the somatic compartment ( Fig. 5j-o) .
In addition to a normal distribution of Dscam[TM1] and Dscam[TM2] in SPT mutant larval γ neurons, no changes can be detected in the localization of other dendritic and axonal proteins within this neuron type ( Fig. 5p-w ). More importantly, the γ neuron-specific axon initial segment (AIS) region, which can be visualized by the lack of Apc2::GFP and Syt::GFP localization 37,40 , develops normally in SPT mutants, further supporting a sphingolipid-independent mechanism of intra-cellular protein localization in γ neurons distinct from α′/β′ and α/β neurons ( Fig. 5r-s , v-w).
These data show that a reduction in sphingolipids does not perturb the overall axonal and dendritic development of MB neurons, but rather interferes with the compartment-specific protein localization. For dendrite localization, Dscam[TM1] seems most sensitive to neuronal sphingolipids compared to other dendritic proteins, whereas all of the analyzed axonal proteins depend on SPT function. 
Dscam[TM1] defines axon-dendritic membrane domains.
Interestingly in addition to somatic aggregates, we also observed changes in the membranous distribution of axonal FasII dependent on dendritic Dscam[TM1] levels. In wild type MB neurons, FasciclinII localizes exclusively in the axonal compartment ( Fig. 6a , n = 18). In addition to the FasII protein aggregation in the soma of SPT mutant MB neurons described above, a reduction in sphingolipids also leads to a shift of the FasII-positive axonal domain into the dendritic calycal region (Figs. 5h, 6d, 11/ 15 = 73% of MB shows calycal shift of FasII). We hypothesized that the dendritic reduction of Dscam[TM1] due to somatic aggregation in SPT mutants may allow axonal FasII to extend into the calyx. To test whether dendritic Dscam isoforms directly influence axonal FasII distribution, we modified Dscam (Fig. 7b, c) . Furthermore, overexpression of Vap33, a transport protein recently identified to mediate Dscam[TM2] axon localization 42 , rescues the axonal branching defects of SPT mutants (Fig. 7a) . These data support a mechanism in which, following sphingolipid reduction, Dscam[TM1] interferes with the axonal localization of Dscam[TM2] in growing MB neurons.
To analyze the interaction of Dscam[TM1] and Dscam[TM2] more directly, we expressed differentially tagged isoforms and studied their distribution in developing MB neurons. In wild-type neurons, the singular expression of Dscam[TM1] and Dscam [TM2] leads to the compartment-specific distribution into MB dendrites and axons, respectively (Fig. 7d, e) (Fig. 8c, i) . Subsequently, Dscam[TM1] aggregates translocate into axons and accumulate in the distal peduncle lobe regions (compare Fig. 8b, d) . Similar somatic Dscam[TM1] aggregate formation and axonal mislocalization could be observed in more mature MB neurons of SPT mutants. Here, pulses of Dscam[TM1] expression in the adult brain using the TARGET system (Gal80 ts ) 43 , led to the protein aggregation phenotype, indicating that sphingolipid-dependency is not restricted to early neuronal differentiation, but may also affect functional circuits (Supplementary Figure 6) . In contrast to the sequential appearance of Dscam[TM1] aggregates in the soma and axons of SPT mutant neurons, Dscam [TM2] aggregates are visible in axons already at an early stage of neuronal development, with an overall reduction of axonal Dscam[TM2] (Fig. 8e, g, i) . In later stages of development, Dscam [TM2] aggregates are highly enriched in the somatic and axonal compartment (Fig. 8f, h, ARTICLE in more detail (Fig. 9 ). Following the onset of Dscam[TM2] expression in wild-type neurons, a homogeneous Dscam[TM2] distribution could be detected in the axonal compartment, with significantly lower Dscam[TM2] levels within the dendrites and no protein localization in the neuronal somata ( Fig. 9a, b) . The membrane-localized Dscam[TM2] rapidly disappeared when transgene expression stopped, indicating a fast Dscam protein turn-over (Fig. 9c ). In addition, the direct comparison of protein perdurance between Dscam[TM2] and mCD8 in newly extending α/β neurons using the transient 201Y-Gal4 driver line revealed a rapid degradation of Dscam[TM2] following axon extension ( Fig. 9g-j) . In SPT mutants, Dscam[TM2] shows a fast aggregation in neuronal cell bodies and these protein aggregates remain stable independently of transgene expression ( Fig. 9d-f ). Interestingly, membrane-localized protein in SPT mutants was removed in a similar temporal pattern as in wild-type neurons, indicating that protein dynamics strongly depend on the intracellular localization (Fig. 9d-f ). Furthermore, in contrast to membrane-integrated Dscam[TM2], most aggregates of Dscam [TM2] are not recognized by an anti-Dscam antibody against the intra-cellular domain 16 , possibly due to substantial conformational changes (Fig. 9k-n) . These data show that Dscam protein is characterized by a rather short half-life upon membrane integration and its degradation is impaired in sphingolipiddeprived neurons due to formation of cytoplasmic aggregates.
Human SPT HSAN-1 mutations lead to Dscam aggregation.
Recently, mutations in the human SPT subunits SPTLC1/ SPTLC2 have been linked to HSAN-1 (Hereditary Sensory and Autonomic Neuropathy type-1) 24, 25, 44, 45 . To determine if these mutations affect neuronal development, we expressed the corresponding SPT mutant forms of the Drosophila protein in developing MBs (Fig. 10 ). Two independent point mutations of a conserved cysteine [C133W (C129W in Drosophila) and C133Y (C129Y in Drosophila)] and one in conserved valine [V144D (V140D in Drosophila)] of SPTLC1 are associated with severe forms of late-onset neurodegeneration 25, 45 . Interestingly, Spt-I B2 , one of the mutations isolated in our genetic mosaic screen, affects a neighboring conserved glycine (G127E) (Fig. 1a ). Following the global expression of Spt-I C129W , Spt-I C129Y and Spt-I V140D throughout development, axon branch segregation defects of MB neurons could be observed ( Fig. 10b-d, m) . In contrast, Spt-I WT expression did not influence neuronal development (Fig. 10a, m) . In addition, MB-specific expression of Spt-I C129W/Y and Spt-I V140D result in impaired Dscam[TM1], as well as FasII transport and the formation of corresponding protein aggregates ( Fig. 10e-l, n) . These data point to aggregation of neuronal cell adhesion molecules as a common subcellular neuronal defect in developmental and disease-linked mutations, providing novel mechanistic insights into the process of HSAN-1 related neurodegeneration.
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Discussion
Neurons provide an excellent example for the coupling of morphological and functional polarity, maintained by a strict control of polarized protein distribution via vesicle transport 1-3 . A major structural component of transport vesicles in addition to proteins are lipids. Here we show that sphingolipids are critical to organize early protein targeting to axonal and dendritic processes in neurons. Mutations in Drosophila SPT, a key enzyme in de novo sphingolipid biosynthesis 26 , lead to a severe reduction in membrane localization of dendrite and axon-specific Dscam isoforms. The impairment of axonal Dscam[TM2] localization disrupts axon branch segregation in extending MB neurons 15 . On the other hand, localized Dscam[TM1] membrane integration, which seems to be dispensable for dendrite patterning in MB 15 , is critical for defining the initial axo-dendritic boundary within neuronal membranes. As sphingolipids are enriched in the transgolgi network and plasma membrane 6 , we propose a model for the role of sphingolipids in localization of dendritic vs. axonal proteins during neuronal development (Fig. 10o) . In extending neurons, Dscam[TM1] and Dscam[TM2] are sorted depending on their localization in sphingolipid low or rich membrane vesicles formed at the trans-golgi network and afterwards targeted to the proximal or distal axonal membrane compartments, respectively. In addition to the development of proper neuronal morphology depending on homophilic repulsion between similar Dscam[TM2] isoforms 12 at the tip of extending axons, Dscam [TM1]-mediated cis-interactions within the proximal axon segment restrict axonal protein localization thereby defining the initial axo-dendritic boundary. This model is strongly supported by our observation that Dscam[TM2] is enriched in sphingolipidrich detergent resistant membrane (DRM) fraction from adult Drosophila brain ( Supplementary Figure 7) .
Consistent with the previous reports, we detected Cer(d14:1/ 20:0) and Cer(d14:1/22:0) as the major ceramide species in Drosophila among other ceramide species with different Fatty acyl chain lengths and saturations 29, 46, 47 . SPT mutants in Drosophila have been previously shown to have reduced levels of sphingolipids [29] [30] [31] [32] [33] . Using mass-spectrometric analysis, we found a significant reduction in the levels of total ceramide, resulting from reduction in amount of 5 ceramide species. Certain ceramide subtypes have been implicated in influencing different biological activities e.g., ceramide (d18:1/16:0) regulates release of CytC from mitochondria whereas ceramide (d18:1/18:0) potentiates mitophagy 48 . In SPT mutants, we could not detect a direct correlation between the affected ceramide species and the axonal phenotype, suggesting that the overall reduction in the levels of ceramides results in disruption of axon-dendritic protein sorting. On the other hand, we did not find any reduction in the total levels of membrane phospholipid PC and another sphingolipid Ceramide-phosphoethanolamine (Cer-PE), a downstream product of ceramide. This suggests that for Cer-PE, some alternative pathways or feedback mechanisms can compensate for the reduced amounts of input ceramide 49 . During neuronal development, polarized transport is established even before axon or dendrite specific microtubule polarity becomes visible 5 . Here we show that sphingolipids play an important role in initial axo-dendritic sorting of Dscam isoforms NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08765-2 ARTICLE required for initial patterning of growing neurons. Interestingly, dynein-dynactin-based retrograde transport has been shown to influence Dscam isoform localization but, in contrast to the sphingolipid-mediated mechanisms described here, controls the maintenance of polarized protein following initial sorting and does not influence neuronal pattering 50 . During dendritic development, the primary function of Dscam is self neurite repulsion 13 whereas in axonal development, Dscam regulates segregation, targeting, collateral formation, as well as arbor size [14] [15] [16] [17] [18] [19] . Not only the function is compartment specific, it also depends on the expression levels of Dscam 18, 19 Various observations suggest that axonal transport depends on sphingolipid-rich vesicles in contrast to vesicular transport into dendrites. By using chemical inhibitors it has been shown that axonal growth depends on sphingolipid biosynthesis and axonal proteins fractionate in detergent insoluble sphingolipid-rich fractions 10, 11 . Furthermore, ER to Golgi transport with vesicles of low sphingolipid content maintains membrane transport to dendrites and is important for dendritic but not axonal morphology 51 . Interestingly, the increased width of sphingolipid/ cholesterol-rich membranes prefer the integration of proteins with longer transmembrane domains 7 . The transmembrane/ juxta-membrane domain of Dscam[TM2] is substantially larger than the one of Dscam[TM1] (71 versus 56 a.a.), which could favor its segregation into sphingolipid-rich vesicles in MB neurons. Supporting the role of sphingolipids in axonal transport, the localization of all tested axonal proteins were affected in SPT mutants while dendritic markers, except Dscam[TM1], showed no change in compartment-specific distribution (Fig. 5 ). Thus, similar to apical transport in epithelial cells, axonal transport in neurons depend on sphingolipids while sphingolipid low vesicles target to dendritic or baso-lateral membranes in neurons or epithelial cells, respectively 52 .
One of the surprising findings of our study is the neuron-type specific requirement of sphingolipids in compartment-specific protein sorting. In SPT mutants, γ neurons showed no developmental morphological defects and reduced Dscam isoform distribution as opposed to α′/β′ or α/β neurons (Figs. 2, 4, 5) . Interestingly in Dscam mutants γ neurons also display a wild-type morphology whereas development of α′/β′ or α/β neurons is severely affected 15, 22 . Although all MB neurons are deriving from a single neuroblast, developmentally and molecularly γ neurons are substantially different from the later-born α′/β′ and α/β neurons. For example, γ neurons undergo developmental pruning and regrowth dependent on dynamic regulation of FasII, not shown by α′/β′ or α/β neurons 53, 54 . A neuronal compartment similar to the AIS in vertebrates has been reported specifically for γ neurons in MB of Drosophila 40 , which is not affected by the absence of sphingolipids. These data suggest the existence of different protein sorting mechanisms even between neurons derived from the same precursors and might support neuron-type specific function in MB-associated learning and memory formation 55 .
In bi-and multipolar neurons, a neurite is selected during early development to become the axonal compartment and subsequently the axon-somatic boundary is defined by AIS assembly 1, 56 . The situation is different in uni-polar neurons where the axo-dendritic boundary has to be specified within a single neurite 2 . Developmental studies have shown that MB neurons as well as projection neurons in the olfactory system first extend an unbranched axon towards their target region before colateral dendritic processes are initiated at the proximal region, raising the question about the underlying mechanism of initial protein targeting for dendrite growth and patterning 57, 58 . Our results described here suggest a 2-step process in which first, Dscam[TM1] vesicles of low sphingolipid content escape anterograde axonal transport and integrate into the proximal neuronal cell membrane ( Fig. 10o) and second, membrane-integrated Dscam[TM1] directly determine the proximal extension of axonal proteins via mutual exclusion (Fig. 10o ). Although we could not test directly a putative complementary instructive function of Dscam[TM2] due to a gain-of-function effect, we speculate that FasII is a readout for the axonal compartment defined by the interactions of Dscam[TM2] with Dscam[TM1]. cis-repulsion between identical Dscam isoforms targeted to dendritic [TM1] or axonal [TM2] compartments can define the axo-dendritic boundary, possibly via activation of differential signaling downstream of the two trans/juxta-membrane Dscam isoforms 14, 59 .
Within growth cones of extending neurons rapid protein degradation balances protein synthesis to ensure contextdependent responsiveness to external guidance cues 60 . Upon targeted membrane localization in growing neurons, Dscam undergoes fast protein turn-over as revealed by growing axons (MB core) specific staining of Dscam antibody 22 . The proposed function of Dscam isoform hyper-variability coupled with isoform-specific interactions allow cell-intrinsic neurite repulsion while ignoring neurites from neighboring neurons 12 . Self versus non-self recognition could be supported by down-regulating Dscam protein levels immediately after a neuron has acquired its final morphology. The presence of a strong PEST motif (PEST score: 14.72) in Dscam suggests ubiquitin-proteasome mediated removal 61 . Interestingly, reduction of sphingolipids result in Dscam molecules escaping fast intrinsic degradation, leading to formation of protein aggregates, which translocate from somato axons, It has been shown before that depending on the context, sphingolipids can nucleate or prevent protein aggregation 62 . These experiments suggest that sphingolipid-dependent segregation of Dscam isoforms is essential to prevent formation of aggregates. Further experiments are needed to address whether the Dscam aggregates are isoform specific or are formed as a result of interaction between the different isoforms.
Human genetic disorders associated with lipid metabolism is an increasing group of inherited form of diseases 63 . HSAN-1, caused by dominant mutations in SPT, is manifested as peripheral sensory loss and axonal degeneration 24, 25, 45 . The current understanding of HSAN-1 pathology involves formation of toxic metabolic intermediates due to changed substrate specificity of SPT 27, 64, 65 . We found that the expression of SPT mutations associated with severe forms of human HSAN-1 pathology, result in neuronal patterning defects and the formation of intra-cellular aggregates of cell surface molecules.
Formation of endogenous protein aggregates is associated with a number of neurodegenerative disorders 66 . In Alzheimer's disease, sphingolipid-rich microdomains can act as a nucleation sites for amyloid β formation, whereas the effect is opposite in case of Prion proteins 62, 66 . On the contrary, changes in the levels of various sphingolipid sub types has been observed in Alzheimer's disease 62, 66 . Thus, sphingolipids being in close proximity with membranous amyloidogenic proteins, influence their biology and thus progression of neurodegenerative disorders. Until now, the formation of endogenous protein aggregates has not been associated with the pathology of inherited disorders of sphingolipid metabolism 63 . We hypothesize that the stable Dscam aggregates formed in SPT mutants/HSAN-1 might interfere with synaptic activity and eventually result in axonal degeneration associated with HSAN-1. It has recently been shown that the expression of HSAN-1 associated allele Spt-I C129W in peripheral neurons of Drosophila larvae leads to reduced nociception 33 . On the other hand, a glia specific knockdown of SPT subunit Lace causes defective glial ensheathment of peripheral nerves in Drosophila 30 . Thus sphingolipids may function not only in neuronal development but also in interaction of neuron and glia, important for neuronal maintenance and function. Finally, our findings regarding the neuron-type specific dependence on sphingolipids for protein sorting could provide novel insights into the differential vulnerability in the context of neurodegeneration.
Methods
Drosophila strains. The flies were reared at 25°C in vials containing standard cornmeal agar medium. Drosophila melanogaster strains were generally obtained from Bloomington Drosophila Stock Center (BDSC), as well as Vienna Drosophila Resource Center (VDRC). Detailed information about the transgenic flies and the exact genotypes of flies used in different experiments is provided as Supplementary methods and Supplementary Table 1 in the Supplementary information file.
Clonal analysis. Single cell clones were generated using different genetic approaches. Mosaic analysis with repressible cell marker (MARCM) 67 was used to generate single homozygous mutant clones in a heterozygous mutant background by mitotic recombination. Flybow (FB1.1B) 68 or a UAS > CD2 > CD8::GFP Flp-out cassette 69 was used to visualized single cells in wild type, as well as mutant background. To generate single cell clones with flybow or Flp-out cassette, midpupae were heat shocked for 20 min or 30 sec at 38°C, respectively. The pupae were then allowed to further develop at 25°C and were dissected after eclosion.
Temporal expression of Dscam[TM1] using the TARGET system. Flies of the desired genotypes were reared at 18°C and then shifted to 29°C for a 48 h period within 1-2 days of eclosion. After 48 h, the flies were dissected and the brains processed for immunohistochemistry.
Sphingosine supplementation of the food. Mutant larvae were reared on standard cornmeal agar medium, without (−) or with ( + ) D-sphingosine (10 μM, sigma, cat. No.-S7049) supplementation. After eclosion, the flies were dissected within 2 days and the brains processed.
Immunohistochemistry. Drosophila melanogaster male and female flies were used 3-5 days post eclosion, unless otherwise specified. Brains and wing discs were dissected in phosphate-buffered saline (PBS) and fixed in 2% paraformaldehyde (PFA) in PBS for 60 min. Samples were rinsed once and washed (4 × 15 min) with PBS-T (PBS containing 0.3% Triton X-100) with constant shaking on a horizontal shaker. The samples were then blocked for 1 h (10% Goat serum in PBS-T) before adding the primary antibody and incubating over-night at 4°C. This was followed by washing with PBS-T (4 × 15 min) and incubating with secondary antibody overnight at 4°C. After washes (PBS-T, 4 × 15 min), the brains were mounted in Vectashield® antifade mounting medium (Vector laboratories). As primary antibodies rat anti-DN-cadherin (DN-Ex #8, DSHB, T. Uemura, 1:20), mouse anti-Fas II (1D4, DSHB, C. Goodman, 1:5), mouse anti-Flamingo (Flamingo#74, DSHB, T. Uemura, 1:20), mouse anti-CD2 (AbD Serotec® MCA154G, 1:1000), and rabbit anti-Hemagglutinin (HA, Sigma-Aldrich, 1:100) antibody were used. Rabbit anti-Dscam antibody 16 (1:1000) was kindly provided by Prof. Dietmar Schmucker. Secondary antibodies (Alexa Fluor®, Molecular Probes™) were obtained from Thermo Fisher Scientific. Cell nuclei were stained with TOTO®-3 solution (Thermo Fisher Scientific, 1:5000).
Confocal microscopy and quantification of phenotypes. The samples were imaged using the confocal microscope TCS SP5II from Leica using 20× glycerol immersion objective. Settings were adjusted using the provided LAS AF software. Image data was processed and analyzed using ImageJ and Adobe Photoshop®. Line scan intensity profiles were generated using the "Plot profile" plugin in ImageJ by drawing a line across the lobe on a single representative confocal plane. Colocalization of Dscam[TM1] and FasII was analyzed using "Colocalisation threshold" plugin in ImageJ. Quantification of the axonal morphology and the Dscam[TM1]:: GFP/Dscam[TM2]::GFP aggregates was done manually by analyzing the confocal Z-stacks and plotted as a percentage of MB where each brain was considered to have two individual MBs. For ORN targeting, the number of antennal lobes (two per brain) showing targeting defects were plotted as a percentage.
Membrane fractionation. Detergent resistant membrane fractions were isolated as described before 70 but with several modifications. Briefly, 200 Drosophila heads were lysed in 700 μl of TNET buffer (100 mM Tris pH 7.5, 150 mM NaCl, 2 mM EGTA, and 1% Triton X-100, 1X protease inhibitor) and then incubated on ice for 30 min. After incubation, the samples were spun at 1000 × g for 5 min at 4°C and supernatant collected. The supernatant was then mixed with 60% Optiprep TM , overlaid with 30 and 5% Optiprep TM . The gradient was spun at 90,000 × g for 5 h at 4°C using swinging bucket Thermo scientific Tft 80.4 rotor. Fractions were collected/numbered from the top and then probed using standard western blotting techniques. Rabbit anti-GFP (Invitrogen Life technologies A6455, 1:1000), mouse anti-syntaxin (DSHB 8C3, 1:100) and mouse anti-alpha-tubulin (DSHB 12G10, 1:200)
Cloning and transgene production. Transgenic fly strains were created using the ɸC31 system 71 . Spt-I (RE58623) and lace (LD36009) cDNA was acquired from the Drosophila Genomics Resource Center (DGRC). TOPO cloning was performed using the pENTR™ Directional TOPO® Cloning Kit from Invitrogen. For the LR recombination reaction the Gateway® LR Clonase® II Enzyme mix from Invitrogen was used. The pUASg-HA.attB destination vector containing the Gateway® cassette, an UAS-site and a 3x hemagglutinin (HA) tag was kindly provided by the Konrad Basler lab, Zürich. The HA epitope tag was selected as previous studies showed that it does not impair SPT function 31, 72 and was fused to the C-terminal of the respective proteins for this study. Site-directed mutagenesis was performed using the QuikChange II XL Site-Directed Mutagenesis Kit from Agilent Technologies. Primers were designed using the QuikChange Primer Design program. The following primers were used for this study: Spt-I forward 5′-CAC CAT GGT GGC CAT CCA ATT G-3′; Spt-I reverse 5′-TAG GAC GGA GCT GGA AAC ACT CTC-3′; Spt-I C129W forward 5′-GAG TTG GAT CTT GGG GAC CTC GGG GCT-3′; Spt-I C129W reverse 5′-AGC CCC GAG GTC CCC AAG ATC CAA CTC-3′; Spt-I C129Y forward 5′-CGC AAG TAC GGA GTT GGA TCT TAT GGA CCT CGG GGC-3′; Spt-I C129Y reverse 5′-GCC CCG AGG TCC ATA AGA TCC AAC TCC GTA CTT GCG-3′; Spt-I V140D forward 5′-TAC GGC ACT ATG GAC GAT CAT CTG GAC CTG GAG G-3′; Spt-I V140D reverse 5′-CCT CCA GGT CCA GAT GAT CGT CCA TAG TGC CGT A-3′; lace forward 5′-CAC CAT GGG CAA TTT CGA CGG CG-3′; lace reverse 5′-GTA AAT GAC GGG ATT CGG ATC GCG-3′. All constructs were verified by sequencing before injection. Successful integration of the construct in the fly genome was verified by overexpression with engrailed-Gal4 in the wing disc of Drosophila 3 rd instar larvae. The resulting expression pattern was visualized using anti-HA antibody. Transgene function was further verified by successful phenotypic rescue of lace 2 /lace k05 by overexpression of Lace WT .
Sequencing of Spt-I/lace mutants. Different Spt-I and lace mutants were sequenced by isolating genomic DNA from a single fly using microLYSIS® Plus kit from microzone and then PCR amplifying using exon specific over-lapping primers designed using freeware Oligoanalyzer 3.1. The domain analysis of Spt-I/Lace was done using EMBL-Ebi InterPro 73 .
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08765-2 ARTICLE Mass-spectrometric analysis. For Mass-spectrometric analysis, 20 male flies of each genotype 4-7 days post eclosion, were snap frozen in liquid nitrogen and then stored at −80 o C until analysis. The experiment was done in 3 biological replicates.
Lipid extraction: The samples (10-16 mg) were weighed in 0.5 mL Precellys® CK14 Lysing Kit tubes (Bertin Instruments, Montigny-le-Bretonneux, France) and methanol was added (3 µL methanol/1 mg tissue). The samples were homogenized using a Precellys 24 tissue homogenizer (Bertin Instruments, Montigny-le-Bretonneux, France) equipped with a Cryolys cooling unit. Lipids were extracted using a modified methyl-tert-butyl ether (MTBE) method 74 . In brief, 20 µL of the sample homogenate were transferred into a glass vial, 10 µL internal standard solution and 120 µL methanol were added. After vortexing 500 µL MTBE were added and the mixture was incubated in a shaker for 10 min at room temperature. A phase separation was induced by adding 145 µL MS-grade water. After 10 min of incubation at room temperature, the samples were centrifuged at 1000 × g for 10 min. An aliquot of 450 µL of the upper phase (organic) was collected and dried in a vacuum concentrator. The samples were reconstituted in 200 µL methanol and used for LC-MS analysis.
Lipid standards: A mixture of deuterium labeled lipids (SPLASH® Lipidomix®) was purchased from Avanti Polar Lipids (Alabaster, AL, USA) and used as an internal standard.
Analysis of lipids using LC-MS: The LC-MS analysis was performed using a Vanquish UHPLC system (Thermo Fisher Scientific) combined with an Orbitrap Fusion™ Lumos™ Tribrid™ mass spectrometer (Thermo Fisher Scientific). Lipid separation was carried out by reversed phase chromatography employing an Accucore C18, 2.6 µm, 150 × 2 mm (Thermo Fisher Scientific) analytical column, column temperature was set to 35°C. Acetonitrile/water (50/50, v/v) solution containing 10 mM ammonium formate and 0.1% formic acid was used as mobile phase A. Mobile phase B consisted of acetonitrile/isopropanol/water (10/88/2, v/v/v) containing 10 mM ammonium formate and 0.1% formic acid. The flow rate was set to 400 µL/min and a gradient of mobile phase B was applied to ensure optimal separation of the analyzed lipid species. The electrospray ionization in positive and negative mode was used for MS analysis, the MS conditions were as follows: capillary voltage, 3500 V (positive) and 3000 V (negative); vaporize temperature, 320°C; ion transfer tube temperature, 285°C; sheath gas, 60 arbitrary units; aux gas, 20 arbitrary units; sweep gas, 1 arbitrary unit. The Orbitrap MS scan mode at 120,000 mass resolution was employed for lipid detection. The scan range was set to 250-1200 m/z for both positive and negative ionization mode, the AGC target was set to 2.0e5 and the intensity threshold to 5.0e3. The data dependent MS2 scan using HCD with fixed collision energy mode set to 35% and inclusion list was employed to obtain MS2 spectra for Cer and Cer-PE lipid species. The data analysis was performed using the TraceFinder software (Thermo Fisher Scientific).
Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
